BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Pseudomonas infection
,
Endothelial cell
,
Hematopoietic cell
,
Doxycycline
,
rs2476601
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
DLL3
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Ascending colon
Fetal brain
Transverse colon
Sigmoid colon
Rectum colon
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Loading...
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Loading...
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Loading...
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Allogeneic CAR T Cells Targeting DLL3 Are Efficacious and Safe in Preclinical Models of Small Cell L…
IL-18-secreting CAR T cells targeting DLL3 are highly effective in small cell lung cancer models.
Pudgy mouse rib deformities emanate from abnormal paravertebral longitudinal cartilage/bone accumula…
The Notch ligand delta-like 3 promotes tumor growth and inhibits Notch signaling in lung cancer cell…
O-fucosylation of DLL3 is required for its function during somitogenesis.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Study of DLL3-CAR-NK Cells in the Treatment of Extensive Stage Small Cell Lung Cancer
Study in Patients With Advanced Cancers Associated With Expression of DLL3
A Phase 1 Study of PT217 in Patients With Advanced Refractory Cancers Expressing DLL3
A Study to Test How Well Different Doses of BI 764532 in Combination With Ezabenlimab Are Tolerated …
Study Comparing Rovalpituzumab Tesirine Versus Topotecan in Subjects With Advanced or Metastatic Sma…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ